SEC Form 4 · accession 0001445064-16-000205
Keenova Therapeutics plc
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Coleman N Lannum III
Officer — Sr.VP, Investor Strategy & IRO
Period of report
Feb 10, 2016
Accepted (ET)
Feb 11, 2016 · 8:47 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001567892
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Feb 10, 2016 | P | 600 | $62.61 | A | 17,340 | D | |
| Ordinary Shares | Feb 10, 2016 | P | 700 | $62.55 | A | 1,600 | I | By wife |
| Ordinary Shares | holding | — | — | — | 75 | I | By son (M) | |
| Ordinary Shares | holding | — | — | — | 45 | I | By son (R) | |
| Ordinary Shares | holding | — | — | — | 45 | I | By son (S) | |
| Ordinary Shares | holding | — | — | — | 20 | I | By mother |
Table II — derivative securities
No Table II lines on this filing.